Literature DB >> 292810

Pulmonary metastases from autochthonous 3-methylcholanthrene-induced murine tumors.

H Wexler, S A Rosenberg.   

Abstract

In three experiments, 87%, 75%, and 85% of female C57BL/6N mice developed pulmonary metastases by 50 days after amputation of legs having autochthonous 3-methylcholanthrene-induced sarcomas. No difference in the incidence of pulmonary metastases was observed when autochthonous tumors of short (49--94 days) and longer (95--119 days) latency periods were compared. These metastasizing autochthonous tumors may provide a useful model for studies of metastases and for the evaluation of cancer therapy in a minimal residual disease setting.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 292810

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

2.  Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium.

Authors:  Steven A Rosenberg; Paul J Spiess; David E Kleiner
Journal:  J Immunother       Date:  2002 May-Jun       Impact factor: 4.456

3.  Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Authors:  A L Asher; J J Mulé; A Kasid; N P Restifo; J C Salo; C M Reichert; G Jaffe; B Fendly; M Kriegler; S A Rosenberg
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

4.  "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally.

Authors:  Isabel García-Cao; Marta García-Cao; Juan Martín-Caballero; Luis M Criado; Peter Klatt; Juana M Flores; Jean-Claude Weill; María A Blasco; Manuel Serrano
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

5.  Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.

Authors:  Ander Matheu; Cristina Pantoja; Alejo Efeyan; Luis M Criado; Juan Martín-Caballero; Juana M Flores; Peter Klatt; Manuel Serrano
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

6.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells.

Authors:  Allan R Albig; Darryl J Becenti; Thessa G Roy; William P Schiemann
Journal:  Microvasc Res       Date:  2008-03-12       Impact factor: 3.514

8.  Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

Authors:  F M Marincola; S Ettinghausen; P A Cohen; L B Cheshire; N P Restifo; J J Mulé; S A Rosenberg
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

9.  Stathmin is dispensable for tumor onset in mice.

Authors:  Sara D'Andrea; Stefania Berton; Ilenia Segatto; Linda Fabris; Vincenzo Canzonieri; Alfonso Colombatti; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

10.  Effects of a combination of cyclophosphamide and human recombinant interleukin 2 on pulmonary metastasis after the surgical removal of a 3-methylcholanthrene-induced primary tumor in autochthonous mice.

Authors:  M Hosokawa; T Yabiku; J Ikeda; Y Sawamura; F Okada; M Komatsumoto; T Tanabe; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1988-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.